{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 336,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "srun (generic function with 3 methods)"
      ]
     },
     "execution_count": 336,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Todo: \n",
    "#   There's some sort of bug where the trial is transitioned/closed multiple times. \n",
    "#   Base p23 n on p1-based power calculation (https://clincalc.com/stats/samplesize.aspx)\n",
    "#   Model decision making agents -- hypers go with d.m. agents\n",
    "#   At present, a pt can be treated with many drugs, including any number of drugs for the very same varient!\n",
    "#       This leads to over-the-top improvments, although it's not entirely obvious that this isn't \n",
    "#       a perfectly plausible strategy (cf. the 9-component GBM treatment), esp. before particular \n",
    "#       precision treatments haven't been approved. There are several things we're ignoring, specifically\n",
    "#       combined toxicity and drug interactions.\n",
    "#   There's a bug where because of the order of ops, the pts can end up with health << 0 just before death\n",
    "#   Allow \"cures\" (at present you only accrue variants, never lose them!) Maybe when healh == 1.0, clear varvac?\n",
    "#   Maybe txs should stop having an effect; possibly bcs the disease mutates away from the target variant\n",
    "#       to a new biomarker configuration. At present this makes no difference bcs we are assuming that we \n",
    "#       test on every cycle and treat to the results of the test (i.e., we \"chase\" the biomarkers). \n",
    "#       But more correctly we would treat with the same drug until it stops working.\n",
    "\n",
    "using Random\n",
    "using Distributions\n",
    "using Printf\n",
    "using CPUTime\n",
    "using PyPlot; const plt = PyPlot\n",
    "\n",
    "global gloglevel = 0\n",
    "function log!(msg,lvl=0) \n",
    "    lvl >= gloglevel ? print(msg) : false\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Globals and Hyperparmaters:\n",
    "##########################################################################################\n",
    "\n",
    "# Values declared as hypers are stored in the ghyps dictionary. This makes it convenient to\n",
    "# save them with run results, but makes access very slow, so use lets to pull them into local around\n",
    "# inner loops. Each entry in the dict is a pair: [current_value, default_value]. In initialization \n",
    "# we call sethyps() to set the current values to either defaiults, or to user-given values.\n",
    "\n",
    "global ghyps = Dict()\n",
    "\n",
    "macro hyp(variable, value); ghyps[:($variable)] = [eval(:($value)),eval(:($value))]; end\n",
    "macro hyp(variable); :(ghyps[($variable)][1]); end # You have to use :symbols to make this work\n",
    "\n",
    "function sethyps(overrides) # overrides is, e.g.: [:foo, 5.2], which will override the default\n",
    "    for (hyp, cd) in ghyps; cd[1]=cd[2]; end # First set everything to default\n",
    "    for (hyp, newval) in overrides; ghyps[hyp][1]=newval; end # Now override anything requested\n",
    "    # Now we have to compute computed hypers -- WWW Note that you can't override computed hypers \n",
    "    # bcs they get recomputed here! (Prob. should test for this and barf!)\n",
    "    ghyps[:hkilledthresh][1]=@hyp(:npts)*@hyp(:txinventiondeathfraction)\n",
    "    # For efficiency this replicates the printlevel test to block the whole loop (much ado ...)\n",
    "    gloglevel <= 5 ? showhyps() : []\n",
    "end\n",
    "    \n",
    "mshowhyps() = for (hyp, cd) in ghyps; @printf(\"%s=%s (default=%s)\\n\", hyp, cd[1], cd[2]) ; end\n",
    "\n",
    "@hyp npts 30\n",
    "@hyp nvs 10 # n variants describing a patient\n",
    "@hyp nyears 50\n",
    "\n",
    "# Only treat when you get below this level (FFF This should have measurement error!)\n",
    "@hyp htxthresh 0.7\n",
    "\n",
    "# Hypers for positive and negative effect sizes:\n",
    "@hyp hesp Dict(:pm => 0.5, :pd => 0.1, :nm => -0.1, :nd => 0.1)\n",
    "\n",
    "# Simplified Beta Hyper Parameters [alpha,beta]\n",
    "@hyp hsbhps Dict(:farleftpeak => [1.5,20], :leftpeak => [3,11], :centered => [10,10], :rightpeak => [11,3])\n",
    "\n",
    "# Get a mean and deviation (usually for normal sampling) centered at the keyed beta, and with the keyed deviation\n",
    "BBMD(Mkey,Dkey) = rand(Beta(@hyp(:hsbhps)[Mkey][1],@hyp(:hsbhps)[Dkey][2])) # BetaBasedMandD\n",
    "\n",
    "# !!! FFF !!! THESE SHOULD BE MOVED INTO INIT TO BE SET AT INIT TIME FFF !!!\n",
    "\n",
    "# Variant occurrance dist (when sampled N>0.5)\n",
    "# ??? Is this too meta? Could just take means from hyper consts rather than sampling them from betas.\n",
    "@hyp hvopds [Normal(BBMD(:farleftpeak,:centered),BBMD(:leftpeak,:centered)) for i in 1:@hyp(:nvs)]\n",
    "\n",
    "# Variant effect size (ves) is sampled from a bimodal mixture:\n",
    "@hyp hmm MixtureModel(Normal[Normal(0.05, 0.01),Normal(0.2, 0.1)],[0.95,0.05])\n",
    "# See the mixture: plt.hist(rand(hmm,1000),100)\n",
    "@hyp hmmd 0.1 # Deviation for N effect sizes centered on mixture model samples (FFF??? Sample this too?)\n",
    "@hyp vesds [Normal(rand(ghyps[:hmm][1]),ghyps[:hmmd][1]) for i in 1:ghyps[:nvs][1]]\n",
    "\n",
    "function printvesds()\n",
    "    log!(\"Variant effect size distributions:\\n\")\n",
    "    for vesd in ghyps[:vesds][1]\n",
    "        log!(@sprintf(\"%s\\n\",vesd))\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Structs, Global stores, Creators, and Printers\n",
    "##########################################################################################\n",
    "\n",
    "# Pateints are described by binary variant vectors, beginning at [0,...,0] and collecting variants at\n",
    "# the rate given by the variant occurrance probability (vop, per year==cycle). Each variant\n",
    "# also has an effect size (ves), which actually the mean and sd of the gaussian effect size, again, per year. \n",
    "# So, as patients develop variants over time, their health, which begins at 1.0, starts declining in accord\n",
    "# with collected variants. The trial could concienvably be a multie-tx field, but at the moment off-trial \n",
    "# treatments are one-shot and dependent on immediate variant tests, so we don't need to record txs other \n",
    "# than trials. The trial will be false if there's no trial.\n",
    "\n",
    "mutable struct pt; id; health; varvec; history; trial; trial_cycles end\n",
    "global gpts = []\n",
    "ptfmt(pt) = @sprintf(\"{Pt#%2d=%.2f%s{%s}}\",pt.id,pt.health,pt.varvec,ctfmt(pt.trial))\n",
    "\n",
    "# A treatment (tx) is just the target variant (by index), an set of effect size distributions (normals), \n",
    "# and an approval status, which is either true, for an approved tx, false for a failed on, or \n",
    "# a clinical trial structure. We create a new targted tx is based on when the number of patients \n",
    "# to die with a particular variant reaches > some % of the population.\n",
    "# The status will either be a trial, or true if it's approved\n",
    "# Effect model (em): [[variant number, effect distrubution]...]\n",
    "mutable struct tx; id; em; status; end\n",
    "global gtxs = []\n",
    "emfmt(em) = string(map(m->@sprintf(\"[%s,N%s]\",m[1],params(m[2])),em))\n",
    "txfmt(tx) = @sprintf(\"<Tx#%2d(%s):%s>\",tx.id,ctshortfmt(tx.status),emfmt(tx.em))\n",
    "\n",
    "# Clinical trials go trough 2 phases: 1 and 2/3 (23). The first phase seeks to power the second phase. When a new \n",
    "# drug is invented, it goes into a phase 1 trials, and can NOT be used except in the trial. Once it \n",
    "# passes phase 1 (if it does), it goes into a specifically-powered phase 23 trial. At THAT point, anyone\n",
    "# can use the drug. Patients who are enrolled in either a phase 1 or phase 2 trial only get the trial\n",
    "# treatment, whereas patients who are NOT in a trial can get any drug that is in phase 2 or beyond. \n",
    "# So an advantage of going into a phase 1 trials is that you get drug before anyone else. The disadvantage\n",
    "# is that you're stuck with that one drug. One question is, why would anyone who could get the drug anyway,\n",
    "# bother going into a phase 2/3 trial? The answer is that they wouldn't, but that's not the world we live in.\n",
    "# So there is another factor, which is that any patient who CAN go into a trial MUST go into a trial (under the\n",
    "# :strict policy). In :strict there is a health cutoff for the trial, which is based on the phase 1 analysis.\n",
    "# Any patient with the target mutation who passes the health cutoff MUST (under :strict) go into the 23 trial.\n",
    "# The :strict policy is actually more like the real world, and it's probably the comparison case. The other\n",
    "# policy (:open), any can get any drug that has passes phase 1, and so there's no reason that anyone would \n",
    "# go into a phase 23 trial, when they can just get tested all the time, and get whatever drug they want, and\n",
    "# any number of them, and change all the time. In fact, :open is to obviously better than :strict, and so not-\n",
    "# the-way-the-world-really-is, that I haven't even bother to implement :open!\n",
    "\n",
    "@hyp phase1_ptsneeded 3 # This looks like it shouldn't be a constant, but in practice, it actually is!\n",
    "@hyp phase1_duration_per_patient 3 # FFF ??? Maybe go to dose escalation, or patient response\n",
    "@hyp phase23_ptsneeded 3 # FFF Compute from Phase 1 results, see: https://clincalc.com/stats/samplesize.aspx\n",
    "@hyp phase23_duration_per_patient 3 # FFF Ditto should be computed based on phase 1, although less critical than n\n",
    "mutable struct ct; id; txs; pts; phase; ptsneeded; duration_per_patient; end\n",
    "global gcts = []\n",
    "ctfmt(ct) = @sprintf(\"[CT%2dph%d,n=%s]\",ct.id,ct.phase,length(ct.pts))\n",
    "ctfmt(status::Bool) = status\n",
    "ctshortfmt(status::Bool) = status\n",
    "ctshortfmt(ct) = @sprintf(\"[CT%2dp%d]\",ct.id,ct.phase)\n",
    "# ??? I tried this with nested maps but it didn't work.\n",
    "report() = for (obs,fmtfn) in ((gpts, ptfmt),(gtxs,txfmt),(gcts,ctfmt)); map(ob->@printf(\"%s\\n\",fmtfn(ob)),obs); end\n",
    "# Once phase 1 trials are completed, they get converted to phase23 and added to the phase23 list.\n",
    "global phase23_trials = []\n",
    "global completed_trials = [] \n",
    "\n",
    "##########################################################################################\n",
    "# Variants (biomarkers)\n",
    "##########################################################################################\n",
    "\n",
    "# Variants are accrued randomly throughout life. \n",
    "\n",
    "# Variant occurs? predicate (i.e., > 0.5) => true/false\n",
    "vop(vn) = (rand(@hyp(:hvopds)[vn]) > 0.5)\n",
    "\n",
    "# Maybe gain a variant (nvs just passed in for efficiency so we don't have to @hyp it)\n",
    "gainvars(varvec,nvs) = [((vop(vn) > 0.5) ? 1 : varvec[vn]) for vn in 1:nvs]\n",
    "\n",
    "# Patient health hit is the amount to reduce the pt's health based on the sum of samples\n",
    "# from all of the accrued variants. \n",
    "function varhealthhit(varvec)\n",
    "    let vesds = @hyp(:vesds)\n",
    "        #varhealthhit(varvec) = reduce(+,[varvec[vn]*rand(gvesds[vn]) for vn in 1:gnvs])\n",
    "        reduce(+,[varvec[vn]*rand(vesds[vn]) for vn in 1:@hyp(:nvs)])\n",
    "    end\n",
    "end\n",
    "\n",
    "##########################################################################################\n",
    "# Treating and creating new treatments\n",
    "##########################################################################################\n",
    "@hyp txinventiondeathfraction 0.1\n",
    "@hyp hkilledthresh 999999.999999 # Gets init'ed in init() [Needs to be same type to avoid conv errs]\n",
    "@hyp hnewtxthresh 0.8\n",
    "\n",
    "# Each time a new treatment is created, it is intially created in the context of a clinical trial,\n",
    "# and as long as there is a trial for that treatment available, that's the preferred way to be treated.\n",
    "# In a phase 1 trials, it's the ONLY way you can get treated, but once the trial is in phase 2/3 (23)\n",
    "# anyone who is not in the trial's target model (meaning doesn't have the excluded variants), can get\n",
    "# the treatment, but patients in the trial MUST stay on the trial regimen, whereas others can get the tx\n",
    "# but aren't required to follow protocol if they end up not doing so well on the drug.\n",
    "\n",
    "function mcantxs() # maybe create a new treatment\n",
    "    # For each of the places where the counts of pts killed by particular variants > kill threshold\n",
    "    # decide whether to create a tx, and create it. (Note that there can be more than one tx/variant!)\n",
    "    let hkilledthresh = @hyp(:hkilledthresh), hnewtxthresh = @hyp(:hnewtxthresh) \n",
    "        killedpts = map(pt->pt.varvec,filter(pt->pt.health==0,gpts))\n",
    "        killedpts != [] ? killedpts = reduce(+,killedpts) : []\n",
    "        log!(@sprintf(\"Patient kill per variant counts: %s (hkilledthresh=%s)\\n\",killedpts, hkilledthresh))\n",
    "        for vn in (killedpts != [] ? findall(x->x>hkilledthresh,killedpts) : []) \n",
    "            if rand(Normal())>hnewtxthresh # FFF Adjust up for the number of txs for this var already on the market!\n",
    "                newtx(vn)\n",
    "            end\n",
    "        end\n",
    "    end\n",
    "end\n",
    "\n",
    "# Although each new tx is targeted to a particular variant, we also create side-effect\n",
    "# variant effects with a certain (small) probability. These are generally slightly negative,\n",
    "# whereas \n",
    "\n",
    "function newtx(vn)  # FFF Rationalize the effect size, and add a clinical trial in the status\n",
    "    # First is the main effect (generally +) and one side effect (-centered) FFF Makes these more flexible\n",
    "    # (Also, the main effect and side effect could cancel if they are the same vn -- prob disallow this! FFF UUU)\n",
    "    # Under one FFF theory, there should be a small side effect for EVERY vn -- too complex, maybe some day)\n",
    "    # A new tx gets a phase 1 trial for just this treatment. FFF trials can be started for multiple\n",
    "    # treatments through a different channel.\n",
    "    let hesp = @hyp(:hesp) \n",
    "        ntx=tx(1+length(gtxs),[[vn,Normal(hesp[:pm],hesp[:pm])],[rand(1:@hyp(:nvs)),Normal(hesp[:nm],hesp[:nd])]],false)\n",
    "        nct = ct(1+length(gcts),[ntx],[],1,@hyp(:phase1_ptsneeded),@hyp(:phase1_duration_per_patient))\n",
    "        ntx.status=nct\n",
    "        push!(gtxs,ntx)\n",
    "        push!(gcts,nct)\n",
    "        log!(@sprintf(\"Creating new tx: %s\\n\",txfmt(ntx)))\n",
    "    end\n",
    "end\n",
    "\n",
    "# When you treat a patient, you treat every variant for which he has a positive test\n",
    "# (tests are assumed to be correct! FFF: Probabalize tests!) If there are several possible\n",
    "# approved treatments for a a given variant, you choose one uniformly at random.\n",
    "\n",
    "function treat(pt)\n",
    "    # If the patient is on a trial, the treatment is determined by the trial, \n",
    "    # otherwise, you can treat per variants\n",
    "    ct = pt.trial\n",
    "    if ct == false\n",
    "        find_trial_or_freetreat(pt)\n",
    "    else\n",
    "        # Treat with the trail treatment, and then update the trial stats\n",
    "        log!(@sprintf(\"Treating pt#%s on trial %s\\n\",pt.id,ct.id))\n",
    "        treatwith(pt,ct.txs[1])\n",
    "        # If the pt has been on the trial the required number of cycles, take them off\n",
    "        if ct.duration_per_patient == pt.trial_cycles\n",
    "            log!(@sprintf(\"Taking pt#%s off trial %s\\n\",pt.id,ct.id))\n",
    "            # Nb. Taking a patient off a trial removes the trial from the patient record, but does not \n",
    "            # remove the patient from the TRIAL's record. We always remember which patients we treated on the trial\n",
    "            pt.trial = false\n",
    "            # Consider closing this trial if this is the last patient, and it's not already closed\n",
    "            # Patients can still be on the trial even though it's technically closed.\n",
    "            # No new ones can be recruited, but ones already on can be recruited.\n",
    "            if (length(ct.pts)==ct.ptsneeded)\n",
    "                # Okay, time to close the trial -- different logic for p1 and p23\n",
    "                if ct.phase == 1\n",
    "                    log!(@sprintf(\"Converting trial %s from phase 1 to phase 23\\n\",ct.id))\n",
    "                    push!(phase23_trials,ct)\n",
    "                    ct.phase = 23\n",
    "                    ct.ptsneeded = @hyp(:phase23_ptsneeded)\n",
    "                    # FFF !!! Compute from phase 1 variance: https://clincalc.com/stats/samplesize.aspx\n",
    "                    ct.duration_per_patient == @hyp(:phase23_duration_per_patient)\n",
    "                else\n",
    "                    log!(@sprintf(\"Trial %s has been completed, approving %s!\\n\",ct.id, ct.txs[1].id))\n",
    "                    push!(completed_trials,ct)\n",
    "                    ct.txs[1].status = true # Mark this treatment as approved!\n",
    "                end\n",
    "            end\n",
    "        else\n",
    "            pt.trial_cycles = pt.trial_cycles + 1\n",
    "        end\n",
    "    end\n",
    "end\n",
    "        \n",
    "function find_trial_or_freetreat(pt)\n",
    "    # The number of patients needed for a trial is used to decide whether a trial is available\n",
    "    # When phase 1 is done, the ptsneeeded will be reset to the appropriate number for p23, and will\n",
    "    # again count up. Once the p23 trial is completed, the ptsneeded will be full up, and won't get\n",
    "    # reset, so the trial will never be selected again.\n",
    "    goodtrials = filter(ct->(applicabletxp(ct.txs[1],pt.varvec)&&(length(ct.pts)<ct.ptsneeded)),gcts) \n",
    "    if goodtrials != []\n",
    "        ct = rand(goodtrials)\n",
    "        pt.trial = ct\n",
    "        pt.trial_cycles = 1\n",
    "        ct.pts=cat(ct.pts,pt,dims=1)\n",
    "        log!(@sprintf(\"Enrolled pt%s in trial %s\\n\",pt.id,ct.id))\n",
    "        treat(pt)\n",
    "    else\n",
    "        log!(@sprintf(\"Free Treating pt#%s\\n\",pt.id))\n",
    "        freetreat(pt)\n",
    "    end\n",
    "end\n",
    "        \n",
    "function applicabletxp(tx,varvec)\n",
    "    # The first elt of the vn array is the target\n",
    "    1==varvec[(map(vn_ves->vn_ves[1],tx.em))[1]]\n",
    "end\n",
    "\n",
    "# If we find a trial that this patient can go on, we do that, otherwise, we treat all the variants they have\n",
    "# The treatment either has to have no attached trials, or anh attached trial must be in phase23. The reason we\n",
    "# might get here even though there are trials for this vn, is that the available trials might be full up.\n",
    "\n",
    "function freetreat(pt)\n",
    "    for vn in findall(v->v==1,pt.varvec)\n",
    "        # Find all possible treatments for this variant:\n",
    "        # And then keep only those that aren't in a trial, or are in phase 23\n",
    "        txs = filter(tx->(tx.status==true)||(tx.status.phase==23),filter(tx->[]!=findall(vn_ves->vn_ves[1]==vn,tx.em),gtxs))\n",
    "        txs != [] ? treatwith(pt,txs[rand(1:end)]) : log!(@sprintf(\"No available treatments!\\n\"))\n",
    "    end\n",
    "end\n",
    "\n",
    "# Treating a patient entails applying an effect size (es) sample from each of the applicable \n",
    "# effect models in the tx. Each em is a pair of a variant number and an effect distribution for that\n",
    "# variant. Even though the variants are chosen to target one particular vn, all the vns that this pt\n",
    "# has will be applied! This models side effects. \n",
    "\n",
    "function treatwith(pt,tx)\n",
    "    log!(@sprintf(\"Treating pt#%s (%.2f) with %s\\n\",pt.id,pt.health,txfmt(tx)))\n",
    "    for (vn,ves) in tx.em\n",
    "        pt.varvec[vn]==1 ? pt.health=pt.health+rand(ves) : false # If this is a side effect, the dist will be negatively biased\n",
    "    end\n",
    "end\n",
    "\n",
    "\n",
    "##########################################################################################\n",
    "# Top Loop\n",
    "##########################################################################################\n",
    "\n",
    "function init(loglevel,overrides)\n",
    "    # Clear collectors\n",
    "    global gloglevel=loglevel\n",
    "    global gpts = [pt(p, 1.0, [0 for i in 1:@hyp(:nvs)], [1.0], false, nothing) for p in 1:@hyp(:npts)] # not on any trials to begin with\n",
    "    global gtxs = []\n",
    "    global gcts = []\n",
    "    global phase23_trials = []\n",
    "    sethyps(overrides)\n",
    "end\n",
    "\n",
    "# Test shows lots of logging whereas run shows none, and averages the average mortalities over all runs.\n",
    "# You can override any hyperparameter on either with overrides=[[:hyp,newval],...]\n",
    "# ** Note that overrides, if you use them, have to be a list of lists, as: overrides=[[:foo,10],[:bar,20]]\n",
    "\n",
    "function test(;overrides=[],loglevel=0,plot=true) # Watch as variants accrue and health declines\n",
    "    init(loglevel,overrides)\n",
    "    log!(printvesds())\n",
    "    let nyears = @hyp(:nyears), htxthresh = @hyp(:htxthresh), nvs = @hyp(:nvs)\n",
    "        for year in 1:nyears\n",
    "            log!(@sprintf(\"\\n-------- %s --------\\n\",year))\n",
    "            for pt in gpts\n",
    "                # There's a sort of which-comes-first problem here about changing health level, then zero'ing it out\n",
    "                # if it's under 0, and then treating or not. Probably this logic could be simplified a bit FFF ???\n",
    "                pt.varvec=gainvars(pt.varvec,nvs)\n",
    "                (pt.health > 0) ? (pt.health=pt.health-varhealthhit(pt.varvec)) : false # Not sure why this syntax requires an else (:) ???\n",
    "                # (FFF Probably do this with tanh instead of these hard limits?)\n",
    "                (pt.health <= 0) ? (pt.health = 0) : (pt.health < htxthresh ? treat(pt) : false)\n",
    "                (pt.health >= 1.0) ? (pt.health = 1.0) : false \n",
    "                push!(pt.history,pt.health)\n",
    "            end\n",
    "            mcantxs()\n",
    "        # report()\n",
    "        end\n",
    "        if plot\n",
    "            plt.plot([[[pt.history for pt in gpts][i][j] for i in 1:ghyps[:npts][1]] for j in 1:nyears]) # UUU Array rotation\n",
    "            #plt.text(nyears-20,-0.2,\"maybe add a label?\")\n",
    "            plt.ylabel(\"Health\")\n",
    "            plt.xlabel(\"Years from Diagnosis\")\n",
    "            show(ghyps)\n",
    "        end\n",
    "        return mean(map(pt->((last(pt.history)!=0.0) ? nyears : (findall(h->h==0.0,pt.history)[1]) ),gpts))\n",
    "    end\n",
    "end\n",
    "\n",
    "function run(;n=10,overrides=[])\n",
    "    let a = []\n",
    "        for i in 1:n\n",
    "            r=test(loglevel=99,overrides=overrides,plot=false)\n",
    "            #@printf(\"%s:%s\\n\",i,r)\n",
    "            push!(a,r)\n",
    "        end\n",
    "        return [mean(a),std(a)]\n",
    "    end \n",
    "end\n",
    "#run(n=10,overrides=[[:htxthresh,0.7]])\n",
    "#test(overrides=[[:htxthresh,0.7]])\n",
    "\n",
    "function srun(overkey,from,to,step;n=10,)\n",
    "    local results = []\n",
    "    let overrider = [[overkey,0.0]]\n",
    "        for val in from:step:to\n",
    "            overrider[1][2]=val\n",
    "            result = run(n=n,overrides=overrider)\n",
    "            @printf(\"@%s=%s:%s\\n\",overkey,val,result)\n",
    "            push!(results,[val,result])\n",
    "        end\n",
    "    end\n",
    "    let x=[x[1] for x in results], y=[x[2][1] for x in results]\n",
    "        plt.scatter(x,y) \n",
    "        plt.plot(x,y) \n",
    "        plt.errorbar(x, y, yerr=[(x[2][2]/sqrt(n)) for x in results])\n",
    "        plt.ylabel(\"Mean Survival\")\n",
    "        plt.xlabel(string(overkey))\n",
    "    end\n",
    "    return(results)\n",
    "end\n",
    "#srun(:txinventiondeathfraction,0.0,1.0,0.1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 340,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "@txinventiondeathfraction=0.0:[8.950000000000001, 0.716515918684571]\n",
      "@txinventiondeathfraction=0.1:[8.309999999999999, 0.8403482523247046]\n",
      "@txinventiondeathfraction=0.2:[7.609999999999999, 0.6679709463630773]\n",
      "@txinventiondeathfraction=0.3:[8.186666666666667, 0.5533734925185905]\n",
      "@txinventiondeathfraction=0.4:[7.4799999999999995, 0.5863046020796296]\n",
      "@txinventiondeathfraction=0.5:[7.503333333333333, 0.5763765058910796]\n",
      "@txinventiondeathfraction=0.6:[7.429999999999998, 0.52055288745907]\n",
      "@txinventiondeathfraction=0.7:[7.296666666666665, 0.4164666186436128]\n",
      "@"
     ]
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "Figure(PyObject <Figure size 640x480 with 1 Axes>)"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "txinventiondeathfraction=0.8:[7.216666666666666, 0.5919730557765549]\n",
      "@txinventiondeathfraction=0.9:[7.186666666666667, 0.27451416118546257]\n",
      "@txinventiondeathfraction=1.0:[6.95, 0.36115384362544467]\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "11-element Array{Any,1}:\n",
       " Any[0.0, [8.950000000000001, 0.716515918684571]]\n",
       " Any[0.1, [8.309999999999999, 0.8403482523247046]]\n",
       " Any[0.2, [7.609999999999999, 0.6679709463630773]]\n",
       " Any[0.3, [8.186666666666667, 0.5533734925185905]]\n",
       " Any[0.4, [7.4799999999999995, 0.5863046020796296]]\n",
       " Any[0.5, [7.503333333333333, 0.5763765058910796]]\n",
       " Any[0.6, [7.429999999999998, 0.52055288745907]]\n",
       " Any[0.7, [7.296666666666665, 0.4164666186436128]]\n",
       " Any[0.8, [7.216666666666666, 0.5919730557765549]]\n",
       " Any[0.9, [7.186666666666667, 0.27451416118546257]]\n",
       " Any[1.0, [6.95, 0.36115384362544467]]"
      ]
     },
     "execution_count": 340,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "srun(:txinventiondeathfraction,0.0,1.0,0.1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 341,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "hnewtxthresh=0.8 (default=0.8)\n",
      "nvs=10 (default=10)\n",
      "hmm=MixtureModel{Normal}(K = 2)\n",
      "components[1] (prior = 0.9500): Normal{Float64}(=0.05, =0.01)\n",
      "components[2] (prior = 0.0500): Normal{Float64}(=0.2, =0.1)\n",
      " (default=MixtureModel{Normal}(K = 2)\n",
      "components[1] (prior = 0.9500): Normal{Float64}(=0.05, =0.01)\n",
      "components[2] (prior = 0.0500): Normal{Float64}(=0.2, =0.1)\n",
      ")\n",
      "phase1_ptsneeded=3 (default=3)\n",
      "hesp=Dict(:pm => 0.5,:nm => -0.1,:pd => 0.1,:nd => 0.1) (default=Dict(:pm => 0.5,:nm => -0.1,:pd => 0.1,:nd => 0.1))\n",
      "hmmd=0.1 (default=0.1)\n",
      "phase23_ptsneeded=3 (default=3)\n",
      "npts=30 (default=30)\n",
      "nyears=50 (default=50)\n",
      "hsbhps=Dict{Symbol,Array{T,1} where T}(:leftpeak => [3, 11],:centered => [10, 10],:rightpeak => [11, 3],:farleftpeak => [1.5, 20.0]) (default=Dict{Symbol,Array{T,1} where T}(:leftpeak => [3, 11],:centered => [10, 10],:rightpeak => [11, 3],:farleftpeak => [1.5, 20.0]))\n",
      "phase23_duration_per_patient=3 (default=3)\n",
      "txinventiondeathfraction=1.0 (default=0.1)\n",
      "phase1_duration_per_patient=3 (default=3)\n",
      "hkilledthresh=30.0 (default=999999.999999)\n",
      "hvopds=Normal{Float64}[Normal{Float64}(=0.13451903105989713, =0.3478522853173512), Normal{Float64}(=0.2531433761193871, =0.14564869494381785), Normal{Float64}(=0.13969190484399274, =0.13536759258317085), Normal{Float64}(=0.38793075295397816, =0.17119457670619834), Normal{Float64}(=0.1014201292818586, =0.38701650204027244), Normal{Float64}(=0.30678820545640334, =0.03962325110919973), Normal{Float64}(=0.22726209674883102, =0.3579609238209489), Normal{Float64}(=0.27276466356888307, =0.5070239314416785), Normal{Float64}(=0.21418201781974827, =0.2914375975311028), Normal{Float64}(=0.050645800544232504, =0.5052429192178753)] (default=Normal{Float64}[Normal{Float64}(=0.13451903105989713, =0.3478522853173512), Normal{Float64}(=0.2531433761193871, =0.14564869494381785), Normal{Float64}(=0.13969190484399274, =0.13536759258317085), Normal{Float64}(=0.38793075295397816, =0.17119457670619834), Normal{Float64}(=0.1014201292818586, =0.38701650204027244), Normal{Float64}(=0.30678820545640334, =0.03962325110919973), Normal{Float64}(=0.22726209674883102, =0.3579609238209489), Normal{Float64}(=0.27276466356888307, =0.5070239314416785), Normal{Float64}(=0.21418201781974827, =0.2914375975311028), Normal{Float64}(=0.050645800544232504, =0.5052429192178753)])\n",
      "vesds=Normal{Float64}[Normal{Float64}(=0.04234919325076586, =0.1), Normal{Float64}(=0.04647143629489025, =0.1), Normal{Float64}(=0.05275593094924686, =0.1), Normal{Float64}(=0.048874852240304786, =0.1), Normal{Float64}(=0.04908804383360802, =0.1), Normal{Float64}(=0.034590111023898466, =0.1), Normal{Float64}(=0.05148051646883419, =0.1), Normal{Float64}(=0.06275173997226131, =0.1), Normal{Float64}(=0.03986475180704879, =0.1), Normal{Float64}(=0.06354159234361915, =0.1)] (default=Normal{Float64}[Normal{Float64}(=0.04234919325076586, =0.1), Normal{Float64}(=0.04647143629489025, =0.1), Normal{Float64}(=0.05275593094924686, =0.1), Normal{Float64}(=0.048874852240304786, =0.1), Normal{Float64}(=0.04908804383360802, =0.1), Normal{Float64}(=0.034590111023898466, =0.1), Normal{Float64}(=0.05148051646883419, =0.1), Normal{Float64}(=0.06275173997226131, =0.1), Normal{Float64}(=0.03986475180704879, =0.1), Normal{Float64}(=0.06354159234361915, =0.1)])\n",
      "htxthresh=0.7 (default=0.7)\n"
     ]
    }
   ],
   "source": [
    "showhyps()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Julia 1.5.2",
   "language": "julia",
   "name": "julia-1.5"
  },
  "language_info": {
   "file_extension": ".jl",
   "mimetype": "application/julia",
   "name": "julia",
   "version": "1.5.2"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 4
}
